The End Brain Cancer Initiative Partners with Telix Pharmaceuticals for TLX101-Px (Pixclara®) and PDUFA Awareness
SEATTLE, WA, UNITED STATES, September 3, 2026 /EINPresswire.com/ -- The FDA has set a Prescription Drug User Fee Act (PDUFA) review goal date of September 11, 2026, for TLX101-Px (Pixclara®), an investigational PET imaging agent developed by Telix …